News | March 12, 2025
Aster DM Healthcare promoters reduce share pledge from 99% to 41%
The new lenders – JP Morgan, HSBC, and Barclays provided fresh funding
The new lenders – JP Morgan, HSBC, and Barclays provided fresh funding
Overall investment in the US facility is estimated around US$50 million
Will add UNLOXCYT (cosibelimab-ipdl), the first and only FDA-approved anti-PD-L1 treatment for metastatic or locally advanced cutaneous squamous cell carcinoma (cSCC) to Sun Pharma's global onco-derm franchise
403 entries from 22 states covering 168 districts highlight groundbreaking initiatives vital to improving national nutrition metrics.
The study demonstrated equivalent efficacy, safety, immunogenicity, and pharmacokinetics between YESINTEK and the reference product Stelara
Amaran Biotech boasts Taiwan’s first fully automated robotic aseptic filling line, offering high-quality and low-waste filling solutions for high-value pharmaceuticals
VITADEETM Green is a 100% plant-based Vitamin D3 suitable for food & nutraceuticals
There are 38.4 million people with diabetes in the United States
Biotech potential of Himalayan territories including Jammu & Kashmir, particularly their agri-biotech potential remains still under-explored
The recent EU approval of MBL's plant has opened new avenues to explore such opportunities
Subscribe To Our Newsletter & Stay Updated
